Discovered in 2015, MOTS-c functions as a signaling molecule that helps the body respond to metabolic stress by improving glucose uptake, enhancing insulin sensitivity, and promoting fat metabolism
They also provide an energy boost, which keeps individuals motivated to stay active and fit long-term, thanks to the increased vitality levels experienced
Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases

Example: 180lb person (82kg) for injury recovery at 5 mcg/kg: 82kg 5mcg = 410mcg per day With 5mg vial + 2ml water = 2,500mcg/ml concentration Draw 0.16ml per injection 12 doses per vial HOW For injury recovery (sprains, tears, tendonitis): Dose: 400-600mcg per day Frequency: Split into 2 doses (morning and evening) Duration: 4-6 weeks minimum Injection site: Near injury OR systemic (abdomen) Results timeline: 2-3 weeks to notice improvement For gut health (IBS, leaky gut, ulcers): Dose: 200-400mcg per day Frequency: Once daily, preferably morning on empty stomach Duration: 6-12 weeks Injection site: Systemic (abdomen) Results timeline: 3-6 weeks For general wellness and prevention: Dose: 150-300mcg per day Frequency: Once daily Duration: Ongoing or 4-week cycles with 2-week breaks Injection site: Systemic (abdomen) Results timeline: Subtle, cumulative benefits Body weight-based dosing: 150 lbs (68kg): Low: 204mcg (3 mcg/kg) Medium: 340mcg (5 mcg/kg) High: 476mcg (7 mcg/kg) 180 lbs (82kg): Low: 246mcg (3 mcg/kg) Medium: 410mcg (5 mcg/kg) High: 574mcg (7 mcg/kg) 200 lbs (91kg): Low: 273mcg (3 mcg/kg) Medium: 455mcg (5 mcg/kg) High: 637mcg (7 mcg/kg) Start at the low end for your goal

These are available at The following three imageJ macro scripts are required: 00-Preporcessing 01-Anisotropy Macro 03-ROI Selection The images were background-corrected using a rolling ball filter where the radius is larger than the largest cell in your images but small enough that distortions in the background are removed, in this case a radius of 100 was used
These studies represent a dedicated program in type 2 diabetes where A1C was the primary outcome. Dr